The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension



Merit Pharmaceuticals LimitedPPA23080/018/001

Main Information

Trade NameDymista 137 micrograms / 50 micrograms per actuation, Nasal Spray Suspension
Active SubstancesFLUTICASONE PROPIONATE
Azelastine hydrochloride
Dosage FormNasal spray, suspension
Licence HolderMerit Pharmaceuticals Limited
Licence NumberPPA23080/018/001

Group Information

ATC CodeR01AD Corticosteroids
R01AD58 fluticasone, combinations

Status

Authorised/WithdrawnAuthorised
Licence Issued09/02/2018
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back